NGEN
NervGen Pharma Corp.
1.90$
-0.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
NervGen Pharma Corp. (NGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.8 million CAD. Tick rows to compare them in a chart.
All figures in millions of CAD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.4 | -3.1 | -3.3 | -4.2 | -5.7 | -3.7 | -4.1 | -3.7 | -5.3 | -10 | -8.3 | -5.8 | -30 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | – | – | – | – | 1.7 | 1.5 | 2.0 | 1.1 | 5.4 | 1.0 | 2.7 | 10 | |
| 0.1 | 0.3 | 0.2 | 0.4 | -0.5 | 0.7 | 0.4 | 0.8 | -0.3 | 0.0 | -1.9 | -0.8 | -2.9 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.1 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| 0.1 | 0.1 | 22 | 0.1 | 0.3 | 0.3 | 1.3 | 4.8 | 1.0 | 19 | 2.8 | 80 | 103 | |
| -1.7 | -2.8 | 18 | -4.1 | -5.2 | -5.1 | -2.8 | 2.0 | -4.7 | 14 | -5.9 | 70 | 73 | |
| -1.4 | -3.1 | -3.3 | -4.2 | -5.7 | -3.7 | -4.1 | -3.7 | -5.3 | -10 | -8.3 | -5.8 | -30 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.